Word: travenol
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...hybrid cell can be cloned indefinitely and the antibodies separated from it. At the least, these monoclonal antibodies could be used for diagnosis of many ills; if proved safe, they might cure them. That all seemed a little remote to Greene, who was a successful marketing executive at Baxter Travenol Laboratories, but it stirred a response in Ivor Royston, an associate professor of medicine at the University of California, San Diego, who saw possibilities and began searching for someone to take charge. A venture- capital executive brought him together with Greene...
...Price, Kaufman & Kammholz; Robert Malott, chairman, FMC Corp.; Marvin Mitchell, former chairman, CBI Industries; Paul Rizzo, vice chairman, IBM; Thomas Roberts Jr., chairman, DeKalb AgResearch; Elaine Yarrington, former executive vice president, Standard Oil of Indiana. The resigning directors: Weston Christopherson, former chairman, Jewel Cos.; Vernon Loucks Jr., president, Baxter Travenol Laboratories...
...business in the apartheid regieme amounts to only 2 percent of its endowment, a tiny fraction compared to the 19 percent of Harvard's $2.3 billion endowment. Radcliffe Treasurer Louis Morrell estimates that Radcliffe has a total of $1 million invested in companies operating in South Africa, including Baxter Travenol, Eastman Kodak, and Schlumberger...
Smith sold his patent rights to Baxter Travenol Laboratories of Deerfield, Ill., which extracted from papain another enzyme, chymopapain, that was more potent and less toxic. Baxter Travenol trade-named its product Disease and obtained U.S. Food and Drug Administration approval in 1963 for its use as an investigational new drug for humans. In twelve years doctors treated some 15,000 patients, and reported that symptoms were relieved in most cases. Meanwhile, Baxter Travenol had applied to the FDA for approval of Disease as a prescription item for any licensed physician...
...when some still disputed new tests seemed to show that Disease had no more effect on slipped discs than did a placebo, Baxter Travenol withdrew its application and stopped producing the enzyme. Furthermore, because the company did not submit a new application to cover investigational treatments, use of Disease became illegal...